Literature DB >> 31515119

Anatomical and functional rehabilitation after total bilateral maxillectomy using a custom-made bone-anchored titanium prosthesis.

A Gueutier1, J-D Kün-Darbois2, L Laccourreye3, R Breheret4.   

Abstract

Surgical reconstruction after a total maxillectomy remains challenging. The standard treatment is the microvascular free flap. In cases of surgical contraindication, oral rehabilitation is usually performed with a palatal obturator prosthesis (PAP). Acceptable anatomical and functional outcomes in terms of speech, mastication, aesthetic appearance, stability, and comfort are not often achieved with a PAP. This technical note describes a technique for reconstruction after total bilateral maxillectomy involving the implantation of a custom-made bone-anchored titanium prosthesis obtained by 3D printing. Good functional and anatomical outcomes were achieved with this technique. It combines the advantages of the obturator prosthesis (short duration of surgery and hospitalization, low morbidity) and free flap (aesthetic/anatomical reconstruction and irremovable comfortable functional rehabilitation). This technique constitutes a new therapeutic alternative for the restoration of large defects after total maxillectomy when free flaps are contraindicated.
Copyright © 2019 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Keywords:  3D printing; bone anchored; juxtaosseous implantation; maxillary rehabilitation; maxillary titanium prosthesis; mini-invasive surgery; obturator prosthesis

Mesh:

Substances:

Year:  2019        PMID: 31515119     DOI: 10.1016/j.ijom.2019.08.014

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  1 in total

1.  Reconstruction of maxillofacial bone defects using patient-specific long-lasting titanium implants.

Authors:  Ho-Kyung Lim; Young-Jun Choi; In-Seok Song; Ui-Lyong Lee; Won-Cheul Choi
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.